Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future...

Area of Science:

• Biochemistry
• Immunology
• Nutrition Science

Background:

• Chronic inflammation is a key factor in noncommunicable diseases like diabetes, cancer, and cardiovascular disease.
• Pattern recognition receptors, particularly Toll-like receptor 4 (TLR4), play a critical role in initiating and sustaining inflammatory responses.
• TLR4 activation triggers multiple inflammatory pathways, increasing the risk and progression of chronic diseases.

Purpose of the Study:

• To review preclinical evidence on bioactive compounds from natural sources that modulate the TLR4 pathway.
• To explore the potential of 'food as medicine' strategies for mitigating inflammation via TLR4 antagonism.
• To identify specific bioactive compounds with anti-inflammatory properties targeting TLR4.

Main Methods:

• Literature review of preclinical studies on bioactive compounds from fruits, vegetables, spices, and herbs.
• Analysis of compounds including curcumin, resveratrol, catechin, cinnamaldehyde, emodin, ginsenosides, quercetin, allicin, and caffeine.
• Examination of mechanisms by which these compounds inhibit TLR4-mediated inflammation.

Main Results:

• Bioactive compounds demonstrate potential to inhibit TLR4-mediated inflammation through various mechanisms.
• Mechanisms include modulating gut microbiota, improving intestinal permeability, inhibiting lipopolysaccharide-TLR4 binding, and reducing TLR4 expression.
• Compounds effectively mitigated inflammation by reducing nuclear factor-κB activation and inflammatory cytokine release.

Conclusions:

• Bioactive compounds from natural sources show promise in regulating the TLR4 pathway and reducing inflammation.
• These findings support the concept of nutritional strategies for managing inflammation-mediated diseases.
• Further clinical studies are warranted to validate the therapeutic potential of these compounds in human diseases.